$3.230
+0.125 (+3.86%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
LXEO Prediction & Forecast by Similar Chart Analysis
Alphio's LXEO stock price prediction model matches the current Lexeo Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.22 (-0.29%). The 1-week path is $3.32 (+2.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Lexeo Therapeutics Inc Stock?
Lexeo Therapeutics Inc is currently not a strong buy. The stock is priced at $3.06, significantly below its 52-week high of $10.99, indicating a potential for recovery but also substantial risk. The RSI is at 55.25, suggesting that the stock is neither overbought nor oversold, which may indicate a stable trend. However, the forward P/E ratio is 5.66, which is low, but the company has been consistently reporting negative net income, with a net loss of $25.9 million in Q4 2024 and a gross profit of $0 in that same quarter. The recent insider selling has increased by 271.82%, which raises concerns about insider confidence. The main risk is the ongoing losses, as evidenced by a projected EPS of -0.33 for the next earnings report on November 4, 2026.
LXEO stock price ended at $3.23 on Wednesday, after rising +3.86%
Lexeo Therapeutics Inc (LXEO) last closed at $3.23, gaining +3.86%. These facts feed the 1-day and 1-week LXEO price prediction above.
Forecast Drivers
Lexeo Therapeutics Inc (LXEO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches LXEO, ranked by similarity.
Seasonality analysis for LXEO
Historically the probability of a positive November return for LXEO is 45.24%. December offers the highest probability of a positive month at 51.16%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for LXEO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $4.78 | $4.96 | $5.32 | +53.41% |
| Dec 2026 | $3.70 | $4.02 | $4.36 | +24.53% |
In 2026, Lexeo Therapeutics Inc (LXEO) is projected to range from $3.70 to $5.32.
Lexeo Therapeutics Inc 2026 monthly forecast
In Nov 2026, Lexeo Therapeutics Inc is projected to average $4.96, with a low of $4.78 and high of $5.32.
In Dec 2026, Lexeo Therapeutics Inc is projected to average $4.02, with a low of $3.70 and high of $4.36.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.